Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes

Acta Diabetologica

Volumn 49, Issue 5, 2012, Pages 371-378

  Tankova, Tsvetalina ^a   Chakarova, Nevena ^a   Dakovska, Lilia ^a   Atanassova, Iliana ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Diabetes; Diagnosis; HbA1c; Prediabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 84867997227     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0334-5     Document Type: Article

References (45)

1. International Diabetes Federation (2009) IDF diabetes atlas, 4th edn. International Diabetes Federation, Brussels
2. Harris MI (1993) Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642-652
3. Harris MI, Klein R, Welborn T, Knuiman MW (1992) Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15:815-819
4. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW et al (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose and impaired glucose tolerance. The Australian diabetes, obesity and lifestyle study (AusDiab). Circulation 116:1-7
5. Diabetes Prevention Program Research Group (2007) The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the diabetes prevention program. Diabet Med 24:137-144
6. Nguyen TT, Wang JJ, Wong TY (2007) Retinal vascular changes in prediabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care 30:2708-2715
7. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M (2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60(1):108-111
8. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. WHO, Geneva
9. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB (2008) A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol 93(7):2447-2453
10. Stern MP, Williams K, Haffner SM (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136:575-581
11. Tamborlane WV, Kollman C, Steffes MW, Ruedy KJ, Dongyuan X, Beck RW et al (2005) Diabetes Research in Children Network (DirecNet) Study Group. Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a diabetes research in children network (DirecNet) study. Pediatr Diabetes 6(1):13-16
12. Kilpatrick ES, Winocour PH, On behalf of the Association of British Clinical Diabetologists (ABCD) (2010) ABCD position statement on haemoglobin A1c for the diagnosis of diabetes. Pract Diab Int 27(7):306-310
13. Lapolla A, Dalfrà MG, Fedele D (2010) Pregnancy complicated by diabetes: what is the best level of HbA1c for conception? Acta Diabetol 47(3):187-192
14. American Diabetes Association (2010) Standards of medical care in diabetes2010. Diabetes Care 33(Suppl 1):S4-S10
15. American Diabetes Association (2011) Standards of medical care in diabetes2011. Diabetes Care 34(Suppl 1):S11-S61
16. Saudek CD, Derr RL, Kalyani RR (2006) Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 295:1688-1697
17. Ollerton RL, Playle R, Ahmed K, Dunstan FD, Luzio SD, Owens DR (1999) Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care 22(3):394-398
18. Petersen PH, Jorgensen LG, Brandslund I, De Fine Olivarius N, Stahl M (2005) Consequences of bias and imprecision in measurements of glucose and HbA1c for the diagnosis and prognosis of diabetes mellitus. Scand J Clin Lab Invest 240:51-60
19. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M (2002) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48(3):436-472
20. Selvin E, Crainiceanu CM, Brancati FL, Coresh J (2007) Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 167(14):1545
21. Consensus Committee (2007) Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and laboratory medicine, and the International Diabetes Federation. Diabetes Care 30:2399-2400
22. Little RR (2003) Glycated hemoglobin standardizationNational Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab 41:1191-1198
23. Sacks DB (2005) ADA/EASD/IDF Working Group of the HbA1c Assay. Global harmonization of hemoglobin A1c. Clin Chem 51:681-683
24. International Expert Committee (2009) International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327-1334
25. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62-S69
26. American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62-S69
27. World Health Organization (2010) Report of a WHO expert consultation. World Health Org., Geneva, 2011. http://www.who.int/chp/media/news/releases/ 2011-1-diabetes/en/index.html
28. Expert Committee on the Diagnosis, Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197
29. Davidson MB, Schriger DL, Peters AL, Lorber B (1999) Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281(13):1203-1210
30. (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44(8):968-983
31. AACE/ACE (2010) A1C position statement. Endocr Pract 16(2):155-156
32. Lindstrom J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725-731
33. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO consultation. WHO, Geneva
34. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G et al (2006) Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil 13(4):555-561
35. Spijkerman AM, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM et al (2002) Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 25:1784-1789
36. Buell C, Kermah D, Davidson MB (2007) Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 30:2233-2235
37. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE (2002) Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the diabetes control and complications trial. Diabetes Care 25(2):275-278
38. Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK et al (1998) Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 21:1221-1225
39. Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H et al (2010) Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 47(3):231-236
40. Mohan V, Vijayachandrika V, Gokulakrishnan K, Anjana RM, Ganesan A, Weber MB et al (2010) A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care 33(3):515-519
41. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA et al (2006) DESIR Study Group. Use of HbA1c in predicting progression to diabetes in french men and women: data from an epidemiological study on the insulin resistance syndrome (DESIR). Diabetes Care 29(7):1619-1625
42. Bennett CM, Guo M, Dharmage SC (2007) HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 24:333-343
43. Inoue K, Matsumoto M, Kobayashi Y (2007) The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res Clin Pract 77:451-458
44. Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD, Early Diabetes Intervention Program (EDIP) (2001) HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the early diabetes intervention program (EDIP). Diabetes Care 24(11):465-471
45. Zhou X, Pang Z, Gao W, Wang S, Zhang L, Ning F et al (2010) Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China. Diabetes Care 33(3):545-550